TANYA ROSS: Open Payments
NPI 1255082749 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 14 payments from 10 companies in 2025. Trend: 2023 $494 · 2024 $1,188 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $168 |
| Dexcom, Inc. | 1 | $102 |
| ABBVIE INC. | 2 | $40 |
| Exact Sciences Corporation | 1 | $25 |
| Corcept Therapeutics | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Optinose US, Inc. | 1 | $16 |
Products named: DEXCOM G7 GSS (161), Wegovy, The Cologuard Plus Collection Kit, QULIPTA, Rybelsus, Korlym, JARDIANCE, NURTEC ODT.
Industry payments across MD — which companies pay providers there.
